Zetagen Therapeutics benefits from its location in the Central New York Biotech Accelerator.
Rotary gasifier technology invented at SUNY Cobleskill will be used to clear forests of dead trees and undergrowth.
Junaid Zubairi’s Flight Data Tracker, which could revolutionize aviation informatics, achieves a commercialization milestone.
Qunnect, LLC was launched to commercialize the technologies of the Quantum Information Technology Lab Directed by Eden Figueroa at Stony Brook University.
RF hosted workshop combined targeted consultations with business and technology experts and a pitch event.
The cleantech Most Valuable Pitch competition featured presentations from ten early stage companies working in solar, wind, biofuels, energy storage and more.
Patent-pending rotary gasifier technology invented at SUNY Cobleskill has tremendous potential in domestic and community use.
The Central New York Biotech Accelerator is one of 17 SUNY business incubators that help to advance innovation and drive economic development throughout NYS.
First ever TAF Most Valuable Pitch competition featured 10 SUNY-affiliated startup companies.
Curamir Therapeutics Inc. licensed a technology that manipulates microRNAs developed by Stony Brook University biochemist Jingfang Ju.
SUNY Oswego’s Adrian Ieta and the SUNY Research Foundation applied for a patent for technology that will allow a rotor to effectively function as an engine.
The RF protects the intellectual property generated at SUNY campuses and works with businesses to translate research discoveries into commercial products.
Part of the Stony Brook Incubator Program, Qunnect, LLC aims to be at the forefront of a historic transformation of the communications and computing industries.
A Stony Brook research created a technology that uses quantum memory applications at room temperatures to securely store and transfer information.
Dr. Gerald Smaldone’s patented pulmonary treatment holds promise for critical care patients.
The technology, developed at the College of Optometry, will help people with disorders of binocular vision to see better.
Stony Brook researchers have developed new chemical compounds that are licensed to Artelo Biosciences as potential drugs to treat pain, inflammation and cancer.
Biotech start-up is an offshoot of Dr. Eckard Wimmer’s groundbreaking research on the poliovirus.
Based on the same principle at play when you sweat, the system is energy efficient and uses no toxic refrigerants.
SUNY Technology Accelerator Fund invests in treatment that may just take breast cancer cells and turn them off.
The patent covers a process for making imines, a class of chemical compounds used in various industries, including pharmaceuticals.